CN Stock MarketDetailed Quotes

301230 PharmaResources

Watchlist
  • 28.07
  • +0.84+3.08%
Market Closed Dec 20 15:00 CST
3.92BMarket Cap561.40P/E (TTM)

PharmaResources Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
6.59%391.4M
11.83%265.76M
7.69%130.73M
2.26%489.72M
10.56%367.21M
15.44%237.66M
16.37%121.39M
6.84%478.88M
12.58%332.13M
8.67%205.87M
Operating revenue
6.59%391.4M
11.83%265.76M
7.69%130.73M
2.26%489.72M
10.56%367.21M
15.44%237.66M
16.37%121.39M
6.84%478.88M
12.58%332.13M
8.67%205.87M
Other operating revenue
----
-25.44%6.37M
----
36.64%9.24M
----
427.56%8.54M
----
281.02%6.76M
----
170.43%1.62M
Total operating cost
24.18%396.61M
32.21%264.86M
29.49%135.33M
9.94%450.09M
9.86%319.39M
9.98%200.33M
13.03%104.5M
13.31%409.4M
18.30%290.74M
14.36%182.15M
Operating cost
24.28%298.42M
35.64%202.57M
33.19%103.78M
11.98%338.51M
13.20%240.12M
16.60%149.34M
17.16%77.92M
10.00%302.3M
12.96%212.12M
4.75%128.08M
Operating tax surcharges
37.04%1.25M
43.74%797.96K
66.97%521.75K
-25.27%1.24M
-26.84%915.16K
-28.30%555.13K
-23.49%312.47K
-5.98%1.66M
-8.49%1.25M
-26.63%774.29K
Operating expense
8.51%9.64M
23.93%6.84M
24.22%3.18M
58.85%12.9M
76.95%8.89M
104.56%5.52M
68.35%2.56M
54.88%8.12M
44.02%5.02M
15.41%2.7M
Administration expense
11.82%49.08M
10.05%31.72M
21.04%16.11M
-15.77%60.69M
-22.93%43.89M
-29.25%28.82M
-6.91%13.31M
24.76%72.05M
35.99%56.94M
51.36%40.74M
Financial expense
173.79%2.32M
103.51%111.85K
92.84%454.45K
92.08%-584.6K
55.44%-3.14M
22.33%-3.19M
-86.52%235.67K
-260.10%-7.38M
-494.75%-7.05M
-449.20%-4.11M
-Interest expense (Financial expense)
139.64%7.05M
134.01%4.75M
130.56%2.41M
13.97%5.46M
-19.27%2.94M
-17.18%2.03M
-17.27%1.05M
89.29%4.79M
134.62%3.64M
252.33%2.45M
-Interest Income (Financial expense)
36.69%-2.64M
48.18%-1.82M
76.32%-724.22K
-91.64%-5.53M
-857.76%-4.16M
-1,698.18%-3.52M
-4,030.13%-3.06M
-366.43%-2.88M
21.85%-434.71K
59.90%-195.68K
Research and development
25.01%35.9M
18.33%22.82M
10.93%11.27M
14.34%37.34M
27.95%28.72M
38.04%19.28M
27.44%10.16M
90.46%32.65M
137.38%22.45M
152.52%13.97M
Credit Impairment Loss
-768.96%-1.32M
-239.30%-1.4M
-1,289.62%-795.77K
-208.10%-273.14K
-146.85%-151.34K
496.16%1.01M
-89.10%66.89K
110.25%252.66K
120.15%323.02K
109.33%168.73K
Asset Impairment Loss
194.84%2.28M
233.95%2.69M
338.62%3.26M
-458.93%-12.09M
-50.42%-2.41M
3.98%-2.01M
12.55%-1.37M
-4.98%-2.16M
30.41%-1.6M
7.44%-2.09M
Other net revenue
597.10%11.64M
1,826.45%9.59M
1,226.30%6.36M
-164.76%-2.18M
167.16%1.67M
-25.57%-555.47K
323.51%479.89K
1,580.07%3.37M
134.37%625.16K
86.75%-442.35K
Fair value change income
69.68%4M
106.16%184.02K
32.56%1.19M
5,716.89%5.58M
1,568.97%2.36M
-1,110.18%-2.99M
327.83%901.4K
-124.98%-99.35K
-127.40%-160.46K
-156.39%-246.76K
Invest income
382.56%3.5M
76.69%5.33M
320.44%1.94M
4.17%628.46K
21.08%726.01K
539.55%3.02M
1.50%461.08K
-66.52%603.32K
32.29%599.62K
57,745.02%471.45K
-Including: Investment income associates
----
----
----
----
----
----
----
101.78%28.89
----
189.50%732.01
Asset deal income
----
----
----
--5.8K
--5.8K
--3.02K
--3.02K
----
----
----
Other revenue
178.36%3.17M
569.38%2.79M
85.95%768.29K
-16.79%3.97M
-22.12%1.14M
-66.88%416.43K
-38.76%413.17K
132.52%4.77M
40.07%1.46M
328.12%1.26M
Operating profit
-87.00%6.43M
-71.45%10.5M
-89.84%1.76M
-48.60%37.44M
17.79%49.49M
58.00%36.77M
49.19%17.37M
-15.95%72.85M
-11.40%42.02M
-13.20%23.27M
Add:Non operating Income
2,225.16%156.95K
1,731.40%123.62K
1,877.39%121.61K
-87.22%26.28K
-96.72%6.75K
-91.65%6.75K
-91.89%6.15K
261.55%205.67K
884.73%205.67K
334.85%80.88K
Less:Non operating expense
-75.08%125.08K
-81.27%52.36K
-79.24%28.45K
446.89%707.82K
579.52%502.02K
414.69%279.58K
743.74%137.02K
-73.52%129.43K
-53.86%73.88K
-41.42%54.32K
Total profit
-86.81%6.47M
-71.04%10.57M
-89.22%1.86M
-49.59%36.76M
16.25%49M
56.65%36.5M
47.31%17.24M
-15.44%72.92M
-10.86%42.15M
-12.86%23.3M
Less:Income tax cost
-386.35%-8.78M
-249.77%-5.41M
-192.27%-1.81M
-114.91%-856.47K
-22.92%3.07M
29.93%3.61M
49.51%1.96M
-54.60%5.75M
-44.92%3.98M
-34.82%2.78M
Net profit
-66.81%15.24M
-51.42%15.98M
-75.99%3.67M
-44.00%37.62M
20.33%45.93M
60.26%32.89M
47.03%15.28M
-8.70%67.18M
-4.72%38.17M
-8.70%20.52M
Net profit from continuing operation
-66.81%15.24M
-51.42%15.98M
-75.99%3.67M
-44.00%37.62M
20.33%45.93M
60.26%32.89M
47.03%15.28M
-8.70%67.18M
-4.72%38.17M
-8.70%20.52M
Net profit of parent company owners
-66.81%15.24M
-51.42%15.98M
-75.99%3.67M
-44.00%37.62M
20.33%45.93M
60.26%32.89M
47.03%15.28M
-8.70%67.18M
-4.72%38.17M
-8.70%20.52M
Earning per share
Basic earning per share
-74.25%0.1099
-54.17%0.11
-78.57%0.03
-55.70%0.35
-9.46%0.4268
-7.69%0.24
-22.22%0.14
-38.28%0.79
-32.66%0.4714
-33.33%0.26
Diluted earning per share
-74.25%0.1099
-54.17%0.11
-78.57%0.03
-55.70%0.35
-9.46%0.4268
-7.69%0.24
-22.22%0.14
-38.28%0.79
-32.66%0.4714
-33.33%0.26
Other composite income
-106.90%-4.82K
-162.94%-51.9K
371.96%82.46K
250.87%69.91K
161.81%82.46K
62.30%82.46K
-112.84%-30.32K
157.91%19.92K
161.03%31.5K
Other composite income of parent company owners
-106.90%-4.82K
-162.94%-51.9K
----
371.96%82.46K
250.87%69.91K
161.81%82.46K
62.30%82.46K
-112.84%-30.32K
157.91%19.92K
161.03%31.5K
Total composite income
-66.88%15.24M
-51.70%15.92M
-76.12%3.67M
-43.85%37.7M
20.45%46M
60.42%32.97M
47.10%15.36M
-9.03%67.15M
-4.59%38.19M
-8.35%20.55M
Total composite income of parent company owners
-66.88%15.24M
-51.70%15.92M
-76.12%3.67M
-43.85%37.7M
20.45%46M
60.42%32.97M
47.10%15.36M
-9.03%67.15M
-4.59%38.19M
-8.35%20.55M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 6.59%391.4M11.83%265.76M7.69%130.73M2.26%489.72M10.56%367.21M15.44%237.66M16.37%121.39M6.84%478.88M12.58%332.13M8.67%205.87M
Operating revenue 6.59%391.4M11.83%265.76M7.69%130.73M2.26%489.72M10.56%367.21M15.44%237.66M16.37%121.39M6.84%478.88M12.58%332.13M8.67%205.87M
Other operating revenue -----25.44%6.37M----36.64%9.24M----427.56%8.54M----281.02%6.76M----170.43%1.62M
Total operating cost 24.18%396.61M32.21%264.86M29.49%135.33M9.94%450.09M9.86%319.39M9.98%200.33M13.03%104.5M13.31%409.4M18.30%290.74M14.36%182.15M
Operating cost 24.28%298.42M35.64%202.57M33.19%103.78M11.98%338.51M13.20%240.12M16.60%149.34M17.16%77.92M10.00%302.3M12.96%212.12M4.75%128.08M
Operating tax surcharges 37.04%1.25M43.74%797.96K66.97%521.75K-25.27%1.24M-26.84%915.16K-28.30%555.13K-23.49%312.47K-5.98%1.66M-8.49%1.25M-26.63%774.29K
Operating expense 8.51%9.64M23.93%6.84M24.22%3.18M58.85%12.9M76.95%8.89M104.56%5.52M68.35%2.56M54.88%8.12M44.02%5.02M15.41%2.7M
Administration expense 11.82%49.08M10.05%31.72M21.04%16.11M-15.77%60.69M-22.93%43.89M-29.25%28.82M-6.91%13.31M24.76%72.05M35.99%56.94M51.36%40.74M
Financial expense 173.79%2.32M103.51%111.85K92.84%454.45K92.08%-584.6K55.44%-3.14M22.33%-3.19M-86.52%235.67K-260.10%-7.38M-494.75%-7.05M-449.20%-4.11M
-Interest expense (Financial expense) 139.64%7.05M134.01%4.75M130.56%2.41M13.97%5.46M-19.27%2.94M-17.18%2.03M-17.27%1.05M89.29%4.79M134.62%3.64M252.33%2.45M
-Interest Income (Financial expense) 36.69%-2.64M48.18%-1.82M76.32%-724.22K-91.64%-5.53M-857.76%-4.16M-1,698.18%-3.52M-4,030.13%-3.06M-366.43%-2.88M21.85%-434.71K59.90%-195.68K
Research and development 25.01%35.9M18.33%22.82M10.93%11.27M14.34%37.34M27.95%28.72M38.04%19.28M27.44%10.16M90.46%32.65M137.38%22.45M152.52%13.97M
Credit Impairment Loss -768.96%-1.32M-239.30%-1.4M-1,289.62%-795.77K-208.10%-273.14K-146.85%-151.34K496.16%1.01M-89.10%66.89K110.25%252.66K120.15%323.02K109.33%168.73K
Asset Impairment Loss 194.84%2.28M233.95%2.69M338.62%3.26M-458.93%-12.09M-50.42%-2.41M3.98%-2.01M12.55%-1.37M-4.98%-2.16M30.41%-1.6M7.44%-2.09M
Other net revenue 597.10%11.64M1,826.45%9.59M1,226.30%6.36M-164.76%-2.18M167.16%1.67M-25.57%-555.47K323.51%479.89K1,580.07%3.37M134.37%625.16K86.75%-442.35K
Fair value change income 69.68%4M106.16%184.02K32.56%1.19M5,716.89%5.58M1,568.97%2.36M-1,110.18%-2.99M327.83%901.4K-124.98%-99.35K-127.40%-160.46K-156.39%-246.76K
Invest income 382.56%3.5M76.69%5.33M320.44%1.94M4.17%628.46K21.08%726.01K539.55%3.02M1.50%461.08K-66.52%603.32K32.29%599.62K57,745.02%471.45K
-Including: Investment income associates ----------------------------101.78%28.89----189.50%732.01
Asset deal income --------------5.8K--5.8K--3.02K--3.02K------------
Other revenue 178.36%3.17M569.38%2.79M85.95%768.29K-16.79%3.97M-22.12%1.14M-66.88%416.43K-38.76%413.17K132.52%4.77M40.07%1.46M328.12%1.26M
Operating profit -87.00%6.43M-71.45%10.5M-89.84%1.76M-48.60%37.44M17.79%49.49M58.00%36.77M49.19%17.37M-15.95%72.85M-11.40%42.02M-13.20%23.27M
Add:Non operating Income 2,225.16%156.95K1,731.40%123.62K1,877.39%121.61K-87.22%26.28K-96.72%6.75K-91.65%6.75K-91.89%6.15K261.55%205.67K884.73%205.67K334.85%80.88K
Less:Non operating expense -75.08%125.08K-81.27%52.36K-79.24%28.45K446.89%707.82K579.52%502.02K414.69%279.58K743.74%137.02K-73.52%129.43K-53.86%73.88K-41.42%54.32K
Total profit -86.81%6.47M-71.04%10.57M-89.22%1.86M-49.59%36.76M16.25%49M56.65%36.5M47.31%17.24M-15.44%72.92M-10.86%42.15M-12.86%23.3M
Less:Income tax cost -386.35%-8.78M-249.77%-5.41M-192.27%-1.81M-114.91%-856.47K-22.92%3.07M29.93%3.61M49.51%1.96M-54.60%5.75M-44.92%3.98M-34.82%2.78M
Net profit -66.81%15.24M-51.42%15.98M-75.99%3.67M-44.00%37.62M20.33%45.93M60.26%32.89M47.03%15.28M-8.70%67.18M-4.72%38.17M-8.70%20.52M
Net profit from continuing operation -66.81%15.24M-51.42%15.98M-75.99%3.67M-44.00%37.62M20.33%45.93M60.26%32.89M47.03%15.28M-8.70%67.18M-4.72%38.17M-8.70%20.52M
Net profit of parent company owners -66.81%15.24M-51.42%15.98M-75.99%3.67M-44.00%37.62M20.33%45.93M60.26%32.89M47.03%15.28M-8.70%67.18M-4.72%38.17M-8.70%20.52M
Earning per share
Basic earning per share -74.25%0.1099-54.17%0.11-78.57%0.03-55.70%0.35-9.46%0.4268-7.69%0.24-22.22%0.14-38.28%0.79-32.66%0.4714-33.33%0.26
Diluted earning per share -74.25%0.1099-54.17%0.11-78.57%0.03-55.70%0.35-9.46%0.4268-7.69%0.24-22.22%0.14-38.28%0.79-32.66%0.4714-33.33%0.26
Other composite income -106.90%-4.82K-162.94%-51.9K371.96%82.46K250.87%69.91K161.81%82.46K62.30%82.46K-112.84%-30.32K157.91%19.92K161.03%31.5K
Other composite income of parent company owners -106.90%-4.82K-162.94%-51.9K----371.96%82.46K250.87%69.91K161.81%82.46K62.30%82.46K-112.84%-30.32K157.91%19.92K161.03%31.5K
Total composite income -66.88%15.24M-51.70%15.92M-76.12%3.67M-43.85%37.7M20.45%46M60.42%32.97M47.10%15.36M-9.03%67.15M-4.59%38.19M-8.35%20.55M
Total composite income of parent company owners -66.88%15.24M-51.70%15.92M-76.12%3.67M-43.85%37.7M20.45%46M60.42%32.97M47.10%15.36M-9.03%67.15M-4.59%38.19M-8.35%20.55M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data